SCOPE’s Clinical Research Leadership Forum

Creating Your Innovation Playbook for the 2020s

August 24-25, 2020 * Hilton La Jolla Torrey Pines * La Jolla, CA

About the event:

From the producers of SCOPE—Summit for Clinical Ops Executives—comes CHI’s and SCOPE’s Clinical Research Leadership Forum to be held August 24-25, 2020 at the beautiful H ilton La Jolla Torrey Pines in La Jolla, California. Hear from an international group of clinical research innovators, trial designers, clin ops leaders, R&D heads and technologists from pharma, biotech, medical device companies, advocacy organizations, disease communities, regulators and academia for the perfect blend of high-quality presentations and intimate networking. Through case studies, interactive panels and roundtable breakout discussions and an active exhibit hall, the summit delivers the real-world experiences and best practices needed to optimize clinical trial innovation, planning and management. It is an executive forum by and for clinical research executives responsible for driving and implementing innovation in their organizations.

lease plan to join us in La Jolla for this special executive gathering this summer…bring your colleagues and your family! REGISTER NOW

Topics be covered:

• Drug development strategy on an organizational and cross-industry level
• Designing and executing a successful development program: Showcases
• Drug development strategy and operations for novel modalities
• Digitalization and automation of clinical trials and emerging technology: artificial intelligence, machine learning, RWD, mobile tech, wearables, digital twin
• Case studies on successful disruption in both large and small organizations
• Strategies in decision making, from analytics to emotional intelligence, and the impact on the R&D organization
• Separating hype from reality in blockchain, AI, digital health and other hot areas
• Patient-centric trials: Integrating the voice of the patient, e-consent, enabling virtual trials, and exploring global home health nursing
• Data Privacy best practices and balancing benefits to open data sharing
• Leveraging RWE to advance innovative trial design, execution, data collection, and integration
• Risk mitigation in vendor selection, contracting, onboarding, and oversight on a global scale
• Driving meaningful adoption "beyond the pilot": Implementing and achieving innovation in an organization
• Key clinical research markets and considerations: China, India, and Latin America
  

Who should attend?

• Senior executives from pharmaceutical and biotech companies responsible for driving and implementing innovation in their organizations
• CEOs, CMOs, CIOs, Vice Presidents, Heads of R&D, Clinical Development, Clinical Innovation, Clinical Operations, Med Affairs, Analytics
• Members of the clinical research and development community working to design trials of the future, improve existing trial operations, and bring therapies to patients more efficiently
• Leaders, managers, innovators, technologists, advocates, researchers and caregivers involved in clinical research, technology integration, innovation, and trial design, planning and execution
• Global clinical trial planning, ops, outsourcing, procurement and partnering leaders responsible for optimizing global outsourcing, technology prioritization, budgeting, and trial launch for US, EU, Asia and Rest of World
• Thought leaders from big pharma, biotech, small pharma, device/diagnostic sponsor organizations, CROs, technology companies, consultancies, start-ups, patients, advocacy community members, regulators, academia, hospitals, sites, and VC/investor community

Would you like to be a presenter? Call for speaking proposals:
We are looking for new case studies, innovative co-presentations, and impactful panel discussions that come together to make the agenda. Do you have a new and innovative story to share? Do you want to co-present with a colleague from a different department? Creative ideas are welcome. The panels and presentation are 25 minutes (15-20 minutes of presentation material and 5-10 minutes for Q&A) and it is an excellent opportunity to share ideas and discuss issues with your peers. We are asking for people to use the online submission form, which is short and easy, by March 4, 2020. Simply fill out the online submission form here

Please note that due to limited speaking slots, preference is given to biopharmaceutical companies, regulators, and large healthcare organizations. Additionally, in order to maintain CHI's neutrality, speakers from the vendor/product/consulting community who provide products and/or services to biopharmaceutical companies are very rarely accepted for main agenda sessions. However, we do offer special opportunities for podium presentation slots based on a variety of sponsorship levels.

For questions or suggestions about the meeting, please contact:

For partnering and sponsorship information, please contact:

For questions or suggestions about the meeting, please contact: